{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:31:21Z","timestamp":1790238681856,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40261-018-0679-4","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T07:17:08Z","timestamp":1532503028000},"page":"977-982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital"],"prefix":"10.1007","volume":"38","author":[{"given":"Margaux","family":"Lafaurie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5534-3575","authenticated-orcid":false,"given":"Liselotte","family":"Pochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Lotiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-0181","authenticated-orcid":false,"given":"Laurent","family":"Molinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-5873","authenticated-orcid":false,"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3510-2475","authenticated-orcid":false,"given":"Emilie","family":"Jouanjus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"679_CR1","unstructured":"SAMHDA. Drug Abuse Warning Network (DAWN). \n                    https:\/\/www.datafiles.samhsa.gov\/study-series\/drug-abuse-warning-network-dawn-nid13516\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2515\/therapie\/2015006","volume":"70","author":"M Lapeyre-Mestre","year":"2015","unstructured":"Lapeyre-Mestre M, Dupui M. Drug abuse monitoring: which pharmacoepidemiological resources at the European level? Th\u00e9rapie. 2015;70:147\u201365.","journal-title":"Th\u00e9rapie"},{"key":"679_CR3","unstructured":"CSP. D\u00e9cret n\u00b0 2017-885 du 9 mai 2017 pris en application de l\u2019ordonnance n\u00b0 2017-51 du 19 janvier 2017 portant harmonisation des dispositions l\u00e9gislatives relatives aux vigilances sanitaires. 2017. \n                    https:\/\/www.legifrance.gouv.fr\/eli\/decret\/2017\/5\/9\/AFSP1706658D\/jo\/texte\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR4","unstructured":"addictovigilance.fr. \n                    http:\/\/addictovigilance.fr\/\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2515\/therapie\/2015009","volume":"70","author":"E Jouanjus","year":"2015","unstructured":"Jouanjus E, Gibaja V, Kahn J-P, Haramburu F, Daveluy A. Signal identification in addictovigilance: the functioning of the French system. Th\u00e9rapie. 2015;70:113\u201331.","journal-title":"Th\u00e9rapie"},{"key":"679_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/fcp.12024","volume":"27","author":"E Frauger","year":"2013","unstructured":"Frauger E, Moracchini C, Le Boisselier R, Braunstein D, Thirion X, Micallef J, et al. OPPIDUM surveillance program: 20\u00a0years of information on drug abuse in France. Fundam Clin Pharmacol. 2013;27:672\u201382.","journal-title":"Fundam Clin Pharmacol"},{"key":"679_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-2125.2010.03897.x","volume":"71","author":"E Jouanjus","year":"2011","unstructured":"Jouanjus E, Leymarie F, Tubery M, Lapeyre-Mestre M. Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. Br J Clin Pharmacol. 2011;71:758\u201365.","journal-title":"Br J Clin Pharmacol"},{"key":"679_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pds.3280","volume":"21","author":"E Jouanjus","year":"2012","unstructured":"Jouanjus E, Pourcel L, Saivin S, Molinier L, Lapeyre-Mestre M. Use of multiple sources and capture-recapture method to estimate the frequency of hospitalizations related to drug abuse. Pharmacoepidemiol Drug Saf. 2012;21:733\u201341.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"679_CR9","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/pds.3369","volume":"21","author":"A Daveluy","year":"2012","unstructured":"Daveluy A, Miremont-Salam\u00e9 G, Kostrzewa A, Couret A, Lacoin L, Lecomte C, et al. Identification of abuse and dependence cases through a hospital database. Pharmacoepidemiol Drug Saf. 2012;21:1344\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"679_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3109\/15563650.2015.1088157","volume":"53","author":"AM Dines","year":"2015","unstructured":"Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, et al. Acute recreational drug and new psychoactive substance toxicity in Europe: 12\u00a0months data collection from the European Drug Emergencies Network (Euro-DEN). Clin Toxicol (Phila). 2015;53:893\u2013900.","journal-title":"Clin Toxicol (Phila)"},{"key":"679_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/pds.4184","volume":"26","author":"DR Poudel","year":"2017","unstructured":"Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. Pharmacoepidemiol Drug Saf. 2017;26:635\u201341.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"679_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jns.2016.01.066","volume":"364","author":"K Rumalla","year":"2016","unstructured":"Rumalla K, Reddy AY, Mittal MK. Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States. J Neurol Sci. 2016;364:191\u20136.","journal-title":"J Neurol Sci"},{"key":"679_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","volume":"36","author":"G Moulis","year":"2015","unstructured":"Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc J-L, Sailler L. French health insurance databases: what interest for medical research? Rev Med Interne. 2015;36:411\u20137.","journal-title":"Rev Med Interne"},{"key":"679_CR14","unstructured":"WHO. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization (WHO) Press; 1992. p. 263. \n                    http:\/\/www.who.int\/classifications\/icd\/en\/GRNBOOK.pdf\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR15","unstructured":"ICD-10 version: 2010. \n                    http:\/\/apps.who.int\/classifications\/icd10\/browse\/2010\/en\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s40261-016-0421-z","volume":"36","author":"J-B Bossard","year":"2016","unstructured":"Bossard J-B, Pont\u00e9 C, Dupouy J, Lapeyre-Mestre M, Jouanjus E. Disproportionality analysis for the assessment of abuse and dependence potential of pregabalin in the French Pharmacovigilance Database. Clin Drug Investig. 2016;36:735\u201342.","journal-title":"Clin Drug Investig"},{"key":"679_CR17","unstructured":"European Medicines Agency (EMA). Guideline for good clinical practice (CPMP\/ICH\/135\/95): international conference on harmonisation of technical requirements for registration of pharmaceutical for human use (ICH). ICH topic E6 (R1). \n                    http:\/\/www.stmichaelshospital.com\/pdf\/research\/reb\/good_clinical_practice.pdf\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR18","unstructured":"WHO. International Nonproprietary Names. \n                    http:\/\/www.who.int\/medicines\/services\/inn\/en\/\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR19","doi-asserted-by":"publisher","first-page":"44428","DOI":"10.1038\/srep44428","volume":"7","author":"T-L Nguyen","year":"2017","unstructured":"Nguyen T-L, Boudemaghe T, Leguelinel-Blache G, Eiden C, Kinowski J-M, Le Manach Y, et al. Identifying life-threatening admissions for drug dependence or abuse (ILIADDA): derivation and validation of a model. Sci Rep. 2017;7:44428.","journal-title":"Sci Rep"},{"key":"679_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00044011-199713010-00006","volume":"13","author":"JC McElnay","year":"1997","unstructured":"McElnay JC, McCallion CR, Al-Deagi F, Scott MG. Development of a risk model for adverse drug events in the elderly. Clin Drug Investig. 1997;13:47\u201355.","journal-title":"Clin Drug Investig"},{"key":"679_CR21","unstructured":"Augmentation des signalements d\u2019intoxications p\u00e9diatriques au cannabis par ingestion accidentelle - Point d\u2019information - ANSM: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. \n                    http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Augmentation-des-signalements-d-intoxications-pediatriques-au-cannabis-par-ingestion-accidentelle-Point-d-information\n                    \n                  . Accessed 2 Jun 2016."},{"key":"679_CR22","unstructured":"Compte-rendu-Seance du 15\/10\/2015-Commission des stupefiants et psychotropes. \n                    http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/dc107bc18c93996878ceae13e9ed1c74.pdf\n                    \n                  . Accessed 9 Jul 2018."},{"key":"679_CR23","doi-asserted-by":"publisher","first-page":"e000638","DOI":"10.1161\/JAHA.113.000638","volume":"3","author":"E Jouanjus","year":"2014","unstructured":"Jouanjus E, Lapeyre-Mestre M, Micallef J, French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3:e000638.","journal-title":"J Am Heart Assoc"},{"issue":"98","key":"679_CR24","first-page":"139","volume":"1973","author":"RB Smith","year":"1960","unstructured":"Smith RB. Cocaine and catecholamine interaction. A review. Arch Otolaryngol Chic Ill. 1960;1973(98):139\u201341.","journal-title":"Arch Otolaryngol Chic Ill"},{"key":"679_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/01.CIR.98.5.385","volume":"98","author":"U Wilbert-Lampen","year":"1998","unstructured":"Wilbert-Lampen U, Seliger C, Zilker T, Arendt RM. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. Circulation. 1998;98:385\u201390.","journal-title":"Circulation"},{"key":"679_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0895-7061(98)00041-7","volume":"11","author":"W Mo","year":"1998","unstructured":"Mo W, Singh AK, Arruda JA, Dunea G. Role of nitric oxide in cocaine-induced acute hypertension. Am J Hypertens. 1998;11:708\u201314.","journal-title":"Am J Hypertens"},{"key":"679_CR27","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.2174\/092986712803988839","volume":"19","author":"L Karila","year":"2012","unstructured":"Karila L, Petit A, Lowenstein W, Reynaud M. Diagnosis and consequences of cocaine addiction. Curr Med Chem. 2012;19:5612\u20138.","journal-title":"Curr Med Chem"},{"key":"679_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/11536020-000000000-00000","volume":"30","author":"E Moratti","year":"2010","unstructured":"Moratti E, Kashanpour H, Lombardelli T, Maisto M. Intravenous misuse of buprenorphine. Clin Drug Investig. 2010;30:3\u201311.","journal-title":"Clin Drug Investig"},{"key":"679_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.psychres.2017.02.067","volume":"253","author":"T Messer","year":"2017","unstructured":"Messer T, Lammers G, M\u00fcller-Siecheneder F, Schmidt R-F, Latifi S. Substance abuse in patients with bipolar disorder: a systematic review and meta-analysis. Psychiatry Res. 2017;253:338\u201350.","journal-title":"Psychiatry Res"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-018-0679-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0679-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0679-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T19:07:41Z","timestamp":1563995261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-018-0679-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-0679-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]},"assertion":[{"value":"25 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was not funded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The study protocol was approved by the French data protection authorities (CNIL approval number 909236v2).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Margaux Lafaurie, Liselotte Pochard, Cl\u00e9mence Lotiron, Laurent Molinier, Maryse Lapeyre-Mestre and Emilie Jouanjus have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}